arrow
Back
P

Ping‐I Hsu

China Medical University Taiwan

43H-index
185Paper Count
5.9KCitation Count
Published Papers 64
Publication Date
Untitled Reply
err2026-02-01
err0
PREAI
errHsu, Ping-, I; Wu, Deng-Chyang; Shih, Chih-An; Liu, Yu-Hwa
errShare
errSave
Sequential changes of antibiotic resistances of Helicobacter pylori in Taiwan from 2019 to 2024
err2025-10-21
err2
PREAI
errWu, Pei-Jui; Tsay, Feng-Woei; Wu, Deng-Chyang; Yang, Jyh-Chin; Chuah, Seng-Kee; Chen, Kuan-Yang; Chen, Chien-Lin; Lee, Chia-Long; Shih, Chih-An; Liu, Yu-Hwa; Shiu, Sz-Iuan; Tai, Wei-Chen; Kuo, Chao-Hung; Lei, Wei-Yi; Kao, Sung-Shuo; Tsai, Tzung-Jiun; Feng, I-Che; Koseki, Mitsuhiro; Hsu, Ping-, I; Sheu, Ming-Jen
errShare
errSave
The efficacy and safety of high-dose amoxicillin-bismuth-potassium competitive acid blocker therapy for Helicobacter pylori infection-A pilot study
err2025-10-01
err0
PREAI
errHsu, Ping-, I; Wu, Deng-Chyang; Chuah, Seng-Kee; Yang, Kai-Chun; Kuo, Chao-Hung; Lee, Chia-Long; Shih, Chih-An; Wu, I-Ting; Shie, Chang-Bih; Tsay, Feng-Woei
errShare
errSave
Future direction of Helicobacter pylori infection treatment
err2025-07-17
err0
PREAI
errPing-I Hsu; Yoshio Yamaoka; Seng-Kee Chuah; Deng-Chyang Wu
errShare
errSave
Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection
err2023-12-19
err4
errOAAI
errChen, Chien-Lin; Wu, I-Ting; Wu, Deng-Chyang; Lei, Wei-Yi; Tsay, Feng-Woei; Chuah, Seng-Kee; Chen, Kuan-Yang; Yang, Jyh-Chin; Liu, Yu-Hwa; Kuo, Chao-Hung; Shiu, Sz-Iuan; Shie, Chang-Bih; Lin, Kuan-Hua; Lee, Chia-Long; Hsu, Ping-, I
errShare
errSave
Application of artificial intelligence in endoscopic image analysis for the diagnosis of a gastric cancer pathogen-Helicobacter pylori infection
err2023-08-17
err14
errOAAI
errLin, Chih-Hsueh; Hsu, Ping-I; Tseng, Chin-Dar; Chao, Pei-Ju; Wu, I-Ting; Ghose, Supratip; Shih, Chih-An; Lee, Shen-Hao; Ren, Jia-Hong; Shie, Chang-Bih; Lee, Tsair-Fwu
errShare
errSave
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial
err2023-03-20
err13
PREAI
errHsu, Ping-, I; Chen, Kuan-Yang; Tai, Wei-Chen; Yang, Jyh-Chin; Tsay, Feng-Woei; Liu, Yu-Hwa; Chen, Chien-Lin; Lee, Chia-Long; Yeh, Hong-Zen; Kuo, Chao-Hung; Chuah, Seng-Kee; Lee, Hsi-Chang; Shie, Chang-Bih; Shiu, Sz-Iuan; Kao, John Y.; Yamaoka, Yoshio; Graham, David Y.; Wu, Deng-Chyang
errShare
errSave
Screening and prevention of hepatitis C virus reactivation during chemotherapy
err2021-08-21
err8
errOAAI
errLi, Yuan-Rung; Hu, Tsung-Hui; Chen, Wen-Chi; Hsu, Ping-, I; Chen, Hui-Chun
errShare
errSave
Efficacy of second-line regimens for Helicobacter pylori eradication treatment: a systemic review and network meta-analysis
err2020-09-03
err13
errOAAI
errChang, Yen-Lin; Tung, Yu-Chun; Tu, Yu-Kang; Yeh, Hong-Zen; Yang, Jyh-Chin; Hsu, Ping-, I; Kim, Sung-Eun; Wu, Ming-Fen; Liou, Wen-Shyong; Shiu, Sz-Iuan
errShare
errSave
Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection
err2020-03-31
err19
errOAAI
errHsu, Ping-, I; Tsay, Feng-Woei; Kao, John Y.; Peng, Nan-Jing; Tsai, Kuo-Wang; Tsai, Tzung-Jiun; Kuo, Chao-Hung; Kao, Sung-Shuo; Wang, Huay-Min; Chen, Yan-Hua; Shie, Chang-Bih; Wu, Deng-Chyang
errShare
errSave
Addition of Carvedilol to Gastric Variceal Obturation Does Not Decrease Recurrence of Gastric Variceal Bleeding in Patients With Cirrhosis
err2019-10-01
err13
PREAI
errChen, Wen-Chi; Hsin, I-Fang; Chen, Ping-Hsien; Hsu, Ping-I; Wang, Yen-Po; Cheng, Jin-Shiung; Lin, Huey-Shyan; Hou, Ming-Chih; Lee, Fa-Yauh
errShare
errSave
Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota
err2019-07-16
err43
errOAAI
errHsu, Ping-I; Pan, Chao-Yu; Kao, John Y.; Tsay, Feng-Woei; Peng, Nan-Jing; Kao, Sung-Shuo; Chen, Yan-Hua; Tsai, Tzung-Jiun; Wu, Deng-Chyang; Tsai, Kuo-Wang
errShare
errSave
Prevalence and risk factors for Barrett's esophagus in Taiwan
err2019-07-07
err12
errOAAI
errChen, Yan-Hua; Yu, Hsien-Chung; Lin, Kung-Hung; Lin, Huey-Shyan; Hsu, Ping-, I
errShare
errSave
Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial
err2018-09-01
err32
PREAI
errHsu, Ping-, I; Tsay, Feng-Woei; Graham, David Y.; Tsai, Tzung-Jiun; Tsai, Kuo-Wang; Kao, John Y.; Peng, Nan-Jing; Kuo, Chao-Hung; Kao, Sung-Shuo; Wang, Huay-Min; Lin, Te-Fu; Wu, Deng-Chyang
errShare
errSave
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance
err2017-11-01
err26
errOAAI
errTsay, Feng-Woei; Wu, Deng-Chyang; Yu, Hsien-Chung; Kao, Sung-Shuo; Lin, Kung-Hung; Cheng, Jin-Shiung; Wang, Huay-Min; Chen, Wen-Chi; Sun, Wei-Chih; Tsai, Kuo-Wang; Hsu, Ping-I
errShare
errSave
Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial
err2017-09-01
err34
PREAI
errHsu, Ping-I; Tsai, Feng-Woei; Kao, Sung-Shuo; Hsu, Wen-Hung; Cheng, Jin-Shiung; Peng, Nan-Jing; Tsai, Kuo-Wang; Hu, Huang-Ming; Wang, Yao-Kuang; Chuah, Seng-Kee; Chen, Angela; Wu, Deng-Chyang
errShare
errSave